Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Oxycodone + pregabalin is a combination medication used for the treatment of neuropathic pain, particularly in cancer patients and those with chronic pain conditions. This combination leverages the complementary mechanisms of action of both drugs to provide enhanced pain relief. Oxycodone is an opioid analgesic that acts on the central nervous system by binding to mu opioid receptors, while pregabalin is an anticonvulsant that decreases pain signals from damaged nerves. Studies show this combination provides more effective pain relief than either drug alone and allows for dose reduction of both agents compared to monotherapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on oxycodone + pregabalin.